Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IL-17A | 100 | ng/mL | 1 | GM-CSF | 280.0 | 66 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | GM-CSF | 276.5 | 42 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | GM-CSF | 293.5 | 52 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | GM-CSF | 245.5 | 64 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | GM-CSF | 318.0 | 61 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | GM-CSF | 264.0 | 61 | |
RA2159 | 1 | GM-CSF | 337.5 | 64 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | GM-CSF | 273.5 | 64 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | GM-CSF | 232.0 | 50 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | GM-CSF | 304.5 | 68 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | GM-CSF | 300.0 | 73 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | GM-CSF | 270.0 | 63 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | GM-CSF | 314.0 | 55 | ||||
N2586 | 1 | GM-CSF | 272.0 | 58 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | GM-CSF | 230.0 | 39 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | GM-CSF | 284.0 | 53 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | GM-CSF | 271.0 | 47 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | GM-CSF | 302.5 | 42 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | GM-CSF | 273.0 | 53 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 1 | GM-CSF | 242.0 | 68 | ||||
RA2159 | EGF | 100 | ng/mL | 1 | GM-CSF | 251.5 | 72 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | GM-CSF | 275.0 | 47 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GM-CSF | 244.5 | 54 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GM-CSF | 268.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GM-CSF | 281.0 | 59 |